Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration
- 19 May 2020
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (5), e13475
- https://doi.org/10.1111/dth.13475
Abstract
During COVID‐19 outbreak there are discordant opinion towards the impact on biologics in psoriatic patients. Thus we performed a single center case‐control study in Lombardia, the Italian region with the higher number of COVID‐19 confirmed cases. We enrolled 1193 PsO patients treated with biologics and small molecules and we used the entire Lombardia population as controls. Notably, 17 PsO patients COVID‐19 confirmed were quarantined at home and 5 hospitalized, no PsO patients were admitted to intensive care unit (ICU) or died. With respect to the general population of Lombardy, patients on biologics were at higher risk to be symptomatic for COVID‐19 (OR 3.43 [95%CI 2.25‐5.73], P < 0.0001), to be self‐quarantined at home (OR 9.05 [95%CI 5.61‐14.61], P < 0.0001) and hospitalized (OR 3.59 [95%CI 1.49‐8.63], P = 0.0044) however not increased risk of ICU admission or death were found. PsO Patients on biologics should be carefully monitored with telemedicine during COVID‐19 outbreak and early treated at home to limit hospital overwhelm.This publication has 10 references indexed in Scilit:
- A subset analysis of efficacy and safety outcomes from phase 3 clinical studies of ixekizumab for the treatment of patients with severe plaque psoriasisJournal of Dermatological Treatment, 2020
- Why tocilizumab could be an effective treatment for severe COVID-19?Journal of Translational Medicine, 2020
- Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, ChinaJournal of Clinical Virology, 2020
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposalThe Journal of Heart and Lung Transplantation, 2020
- Strength and deformability of a low-porosity sandstone under true triaxial compression conditionsInternational Journal of Rock Mechanics and Mining Sciences, 2020
- Lifestyle changes for treating psoriasisEmergencias, 2019
- Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic EfficacyBioMed Research International, 2018
- Safety of Systemic Agents for the Treatment of Pediatric PsoriasisJAMA Dermatology, 2017
- Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine modelBiochemical Pharmacology, 2017
- Increased airway inflammation in patients with psoriasisBritish Journal of Dermatology, 2016